Overlooked Stocks: LIFE, LEV, HUT
b'aTyr Pharma (LIFE) is a biotherapeutics company that researches extracellular functionality and signaling pathways of tRNA synthetases. Oppenheimer recently raised price target on the stock to $20 as it is up 132% this year. Next, Lion Electric (LEV) stock shares are up 14% this week. This company is a maker of electric commercial vehicles. The final stock that George Tsilis discusses is Hut 8 Mining (HUT) with shares up 277% this year.'